The effect of stopping dapsone treatment for two months and then restarting it in full dosage in patients with moderately severe erythema nodosum leprosum.
D003622:Dapsone / Q000008:administration & dosage* / Q000627:therapeutic use; D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D010919:Placebos
D010919:Placebos; D003622:Dapsone